Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, January 26, 2016
Broad Institute Genomic Services has partnered with Takeda Pharmaceutical Company Limited to perform genomic analysis on patient samples from a Phase 3 clinical trial of NINLARO® (ixazomib), an oral proteasome inhibitor that was recently approved by ...
read more
Amphastar announced the FDA has approved its ANDA for Succinylcholine Chloride Injection USP, 200 mg/10 mL Multiple-Dose Vial.
read more
Tuesday, February 06, 2018
HemaCare and Charles River Laboratories have formed a partnership to advance human immune system research by developing a more efficient and reliable method of working with humanized mice.
read more
Tuesday, December 22, 2020
Avacta Group has entered into a license agreement with Astrea Bioseparations for the use of the Affimer platform in affinity purification applications.
read more
Thursday, September 01, 2022
Ginkgo Bioworks announced that Behzad Mahdavi, Ph.D., MBA, joined as senior vice president of biopharma manufacturing and life sciences tools.
read more
The FDA has released draft guidance for industry “Labeling for Biosimilar Products.” This guidance provides an overview of FDA’s recommendations for biosimilar product labeling and is intended to assist industry in developing draft labeling for ...
read more
Catalent Pharma Solutions welcomed Lexicon Pharmaceuticals’ announcement that Xermelo, has been approved by the U.S. Food and Drug Administration (FDA).
read more
Penta ID Innovation and CROMSOURCE announced their partnership focused on improving drug development for pediatric patients.
read more
Ginkgo Bioworks and Swissaustral announced a new partnership to design strains of microorganisms that will produce industrial enzymes at scale.
read more
Wednesday, December 06, 2017
Charles River Laboratories announced the expansion of its CRISPR/Cas9 service offering with the addition of a license from ERS Genomics Limited.
read more
Cartherics Pty Ltd and Catalent have signed an amended commercial license agreement enabling the use of a Catalent cGMP compliant induced pluripotent stem cells (iPSC) line for the manufacture and commercialization of Cartherics’ iPSC-derived ...
read more
Stevanato Group S.p.A. announced the appointment of Ugo Gay as its new Chief Operations Officer (COO).
The addition of Ugo Gay underscores Stevanato Group’s unwavering commitment to driving operational efficiency, process standardization, and ...
read more
Starting in July, the commercial brand for Eurofins Alphora will be Eurofins CDMO, falling under the CDMO umbrella in conjunction with Eurofins Amatsigroup.
read more
Abzena has invested $60m into a new facility for late phase and commercial cGMP manufacturing.
read more
Tuesday, February 02, 2021
Avacta Group announce AffyXell Therapeutics, the joint venture with Daewoong Pharmaceutical has closed a Series A venture capital investment of $7.3 million to further develop its pipeline of next generation cell and gene therapies.
read more